81 FR 58948 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 166 (August 26, 2016)

Page Range		58948-58948
FR Document		2016-20446

Federal Register, Volume 81 Issue 166 (Friday, August 26, 2016)

[Federal Register Volume 81, Number 166 (Friday, August 26, 2016)]
[Notices]
[Page 58948]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2016-20446]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Diabetes and Digestive and Kidney Diseases; 
Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; R18 and R34.
    Date: September 15, 2016.
    Time: 9:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Michele L. Barnard, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301) 
594-8898, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; NIDDK Ancillary Studies 
(R01).
    Date: September 15, 2016.
    Time: 11:00 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Blvd., Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Jian Yang, Ph.D., Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 7111, 
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-7799, 
[email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity.
    Date: September 19, 2016.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Michele L. Barnard, Ph.D., Scientific Review 
Officer, Review Branch, DEA, NIDDK, National Institutes of Health, 
Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892-2542, (301) 
594-8898, [email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-13-228: Biomarkers 
for Diabetes, Digestive, Kidney and Urologic Diseases using NIDDK 
Biorepository Samples (R01).
    Date: September 21, 2016.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Najma Begum, Ph.D., Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 7349, 
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894, 
[email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-16-126: High Impact, 
Interdisciplinary Science in DDK Research Areas (RC2)-CKD.
    Date: September 26, 2016.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Najma Begum, Ph.D., Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 7349, 
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894, 
[email protected].

    Name of Committee: National Institute of Diabetes and Digestive 
and Kidney Diseases Special Emphasis Panel; PAR-15-067: NIDDK Multi-
Center Clinical Study Cooperative Agreement (U01): CKD and Mineral 
Bone Disorders in Children.
    Date: September 27, 2016.
    Time: 12:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate cooperative agreement 
applications.
    Place: National Institutes of Health, Two Democracy Plaza, 6707 
Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Najma Begum, Ph.D., Scientific Review Officer, 
Review Branch, DEA, NIDDK, National Institutes of Health, Room 7349, 
6707 Democracy Boulevard, Bethesda, MD 20892-5452, (301) 594-8894, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.847, 
Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive 
Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology 
and Hematology Research, National Institutes of Health, HHS)


    Dated: August 22, 2016.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-20446 Filed 8-25-16; 8:45 am]
 BILLING CODE 4140-01-P

58948 Federal Register / Vol. 81, No. 166 / Friday, August 26, 2016 / Notices

III. Potential Responders Name of Committee: National Institute of Date: September 26, 2016.
Diabetes and Digestive and Kidney Diseases Time: 12:00 p.m. to 2:00 p.m.
HHS invites input from a broad range Special Emphasis Panel; R18 and R34. Agenda: To review and evaluate grant
of stakeholders including individuals Date: September 15, 2016. applications.
and organizations that have interests in Time: 9:00 a.m. to 5:00 p.m. Place: National Institutes of Health, Two
maternal immunization efforts and the Agenda: To review and evaluate grant Democracy Plaza, 6707 Democracy
role of HHS in advancing those efforts. applications. Boulevard, Bethesda, MD 20892 (Telephone
Examples of potential responders Place: Bethesda Marriott Suites, 6711 Conference Call).
include, but are not limited to, the Democracy Boulevard, Bethesda, MD 20817. Contact Person: Najma Begum, Ph.D.,
Contact Person: Michele L. Barnard, Ph.D., Scientific Review Officer, Review Branch,
following:
Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health,
—General public; DEA, NIDDK, National Institutes of Health, Room 7349, 6707 Democracy Boulevard,
—advocacy groups, non-profit Room 7353, 6707 Democracy Boulevard, Bethesda, MD 20892–5452, (301) 594–8894,
organizations, and public interest Bethesda, MD 20892–2542, (301) 594–8898, begumn@niddk.nih.gov.
organizations; barnardm@extra.niddk.nih.gov.
Name of Committee: National Institute of
—academics, professional societies, and Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases
healthcare organizations; Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; PAR–15–067:
—public health officials and Special Emphasis Panel; NIDDK Ancillary NIDDK Multi-Center Clinical Study
immunization program managers; Studies (R01). Cooperative Agreement (U01): CKD and
—obstetrical care provider groups Date: September 15, 2016. Mineral Bone Disorders in Children.
including all physician and non- Time: 11:00 a.m. to 12:30 p.m. Date: September 27, 2016.
Agenda: To review and evaluate grant
physician providers that administer applications.
Time: 12:00 p.m. to 2:00 p.m.
healthcare services to pregnant Agenda: To review and evaluate
Place: National Institutes of Health, Two
women, including pharmacists; and cooperative agreement applications.
Democracy Plaza, 6707 Democracy Blvd.,
—representatives from the private Place: National Institutes of Health, Two
Bethesda, MD 20892 (Telephone Conference
sector. Democracy Plaza, 6707 Democracy
Call).
Contact Person: Jian Yang, Ph.D., Scientific Boulevard, Bethesda, MD 20892 (Telephone
When responding, please self-identify Conference Call).
with any of the above or other categories Review Officer, Review Branch, DEA,
NIDDK, National Institutes of Health, Room Contact Person: Najma Begum, Ph.D.,
(include all that apply) and your name. Scientific Review Officer, Review Branch,
7111, 6707 Democracy Boulevard, Bethesda,
Anonymous submissions will not be MD 20892–5452, (301) 594–7799, yangj@ DEA, NIDDK, National Institutes of Health,
considered. Written submissions should extra.niddk.nih.gov. Room 7349, 6707 Democracy Boulevard,
not exceed six (6) pages. Please do not Bethesda, MD 20892–5452, (301) 594–8894,
Name of Committee: National Institute of begumn@niddk.nih.gov.
send proprietary, commercial, financial, Diabetes and Digestive and Kidney Diseases
business, confidential, trade secret, or Special Emphasis Panel; Time-Sensitive (Catalogue of Federal Domestic Assistance
personal information. Obesity. Program Nos. 93.847, Diabetes,
Date: September 19, 2016. Endocrinology and Metabolic Research;
Dated: August 16, 2016. 93.848, Digestive Diseases and Nutrition
Time: 2:00 p.m. to 4:00 p.m.
Bruce Gellin, Agenda: To review and evaluate grant Research; 93.849, Kidney Diseases, Urology
Executive Secretary, National Vaccine applications. and Hematology Research, National Institutes
Advisory Committee, Deputy Assistant Place: National Institutes of Health, Two of Health, HHS)
Secretary for Health, Director, National Democracy Plaza, 6707 Democracy
Vaccine Program Office. Boulevard, Bethesda, MD 20892 (Telephone Dated: August 22, 2016.
[FR Doc. 2016–20525 Filed 8–25–16; 8:45 am] Conference Call). David Clary,
BILLING CODE 4150–44–P Contact Person: Michele L. Barnard, Ph.D., Program Analyst, Office of Federal Advisory
Scientific Review Officer, Review Branch, Committee Policy.
DEA, NIDDK, National Institutes of Health, [FR Doc. 2016–20446 Filed 8–25–16; 8:45 am]
Room 7353, 6707 Democracy Boulevard,
DEPARTMENT OF HEALTH AND BILLING CODE 4140–01–P
Bethesda, MD 20892–2542, (301) 594–8898,
HUMAN SERVICES barnardm@extra.niddk.nih.gov.
National Institutes of Health Name of Committee: National Institute of
Diabetes and Digestive and Kidney Diseases DEPARTMENT OF HEALTH AND
Special Emphasis Panel; PAR–13–228: HUMAN SERVICES
National Institute of Diabetes and
Biomarkers for Diabetes, Digestive, Kidney
Digestive and Kidney Diseases; Notice and Urologic Diseases using NIDDK National Institutes of Health
of Closed Meetings Biorepository Samples (R01).
Date: September 21, 2016. National Institute of Diabetes and
Pursuant to section 10(d) of the Digestive and Kidney Diseases; Notice
Time: 12:00 p.m. to 3:00 p.m.
Federal Advisory Committee Act, as of Closed Meetings
Agenda: To review and evaluate grant
amended (5 U.S.C. App.), notice is applications.
hereby given of the following meetings. Place: National Institutes of Health, Two Pursuant to section 10(d) of the
The meetings will be closed to the Democracy Plaza, 6707 Democracy Federal Advisory Committee Act, as
public in accordance with the Boulevard, Bethesda, MD 20892 (Telephone amended (5 U.S.C. App.), notice is
provisions set forth in sections Conference Call). hereby given of the following meetings.
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Contact Person: Najma Begum, Ph.D., The meetings will be closed to the
as amended. The grant applications and Scientific Review Officer, Review Branch, public in accordance with the
the discussions could disclose DEA, NIDDK, National Institutes of Health, provisions set forth in sections
mstockstill on DSK3G9T082PROD with NOTICES

Room 7349, 6707 Democracy Boulevard,
confidential trade secrets or commercial Bethesda, MD 20892–5452, (301) 594–8894,
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
property such as patentable material, begumn@niddk.nih.gov. as amended. The grant applications and
and personal information concerning Name of Committee: National Institute of
the discussions could disclose
individuals associated with the grant Diabetes and Digestive and Kidney Diseases confidential trade secrets or commercial
applications, the disclosure of which Special Emphasis Panel; PAR–16–126: High property such as patentable material,
would constitute a clearly unwarranted Impact, Interdisciplinary Science in DDK and personal information concerning
invasion of personal privacy. Research Areas (RC2)–CKD. individuals associated with the grant

VerDate Sep<11>2014 21:17 Aug 25, 2016 Jkt 238001 PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 E:\FR\FM\26AUN1.SGM 26AUN1

Document Created: 2016-08-26 10:40:29
Document Modified: 2016-08-26 10:40:29

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		September 15, 2016.
FR Citation		81 FR 58948

81 FR 58948 - National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 166 (August 26, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health